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Abstract
Mesenchymal stromal cells (MSC) are tissue-resident stromal cells capable of modulating
immune responses, including leukocyte recruitment by endothelial cells (EC). However, the
comparative potency of MSC from different sources in suppressing recruitment, and the
necessity for close contact with endothelium remain uncertain, although these factors have
implications for use of MSC in therapy. We thus compared the effects of MSC isolated from
bone marrow, Wharton’s jelly, and trabecular bone on neutrophil recruitment to cytokine-
stimulated EC, using co-culture models with different degrees of proximity between MSC
and EC. All types of MSC suppressed neutrophil adhesion to inflamed endothelium but not
neutrophil transmigration, whether directly incorporated into endothelial monolayers or sep-
arated from them by thin micropore filters. Further increase in the separation of the two cell
types tended to reduce efficacy, although this diminution was least for the bone marrow
MSC. Immuno-protective effects of MSC were also diminished with repeated passage; with
BMMSC, but not WJMSC, completing losing their suppressive effect by passage 7. Condi-
tioned media from all co-cultures suppressed neutrophil recruitment, and IL-6 was identified
as a common bioactive mediator. These results suggest endogenous MSC have a homeo-
static role in limiting inflammatory leukocyte infiltration in a range of tissues. Since released
soluble mediators might have effects locally or remotely, infusion of MSC into blood or direct
injection into target organs might be efficacious, but in either case, cross-talk between EC
and MSC appears necessary.
Introduction
Mesenchymal stromal cells (MSC) are multi-potent tissue-resident precursors which may differ-
entiate for tissue repair but are also able to modulate immune responses in their undifferentiated
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state [1]. Numerous studies, for instance, have demonstrated the ability of MSC to suppress T-
cell proliferation and differentiation of dendritic cells (e.g. reviewed [2–3]). In addition, we have
shown recently that cross-talk betweenMSC and endothelial cells (EC) down-regulated leukocyte
recruitment by EC responding to inflammatory cytokines [4]. Thus, MSCmay be endogenous
regulators of leukocyte entry into tissue, or might be delivered therapeutically to limit acute
inflammatory infiltrates or to resolve chronic inflammatory disease.
Several questions arise in relation to these regulatory effects. It is not known whether the
ability of MSC to modulate leukocyte recruitment is tissue specific or whether exogenous MSC
derived from different sources have equal therapeutic potential in this respect. Tissue specific-
ity is suggested by growing evidence that the MSC niche varies between tissues and that diver-
sity in tissue microenvironment lead to functional differences [5–8]. These variations between
MSC may not be maintained after extraction and cell culture, since in general, immunomodu-
latory effects of MSC are thought to diminish with in vitro expansion [9–12]. Nevertheless,
MSC from bone marrow (BMMSC) have been reported to inhibit lymphocyte proliferation to
a similar [13–14] or lesser extent than those from adipose tissue (ADMSC) [15] or placental-
derived MSC [16]. In vivo, systemic administration of human umbilical cord-derived or
BMMSC ameliorated markers of disease in a murine model of Systemic Lupus Erythematosus
[16–17]. On the other hand, murine BMMSC were more effective than ADMSC at preserving
tissue viability and promoting angiogenesis in response to hind limb ischemia [18].
It is also uncertain how important for their efficacy are the proximity or contact of MSC
with EC, and the route of delivery used for therapy. Most pre-clinical in vivo studies have used
intravenous infusion of MSC, with evidence on balance showing therapeutic benefit [19]. Since
MSC have a very low homing efficiency with few cells reaching the target tissue [20], this sug-
gests that MSC may release soluble mediators systemically that exert effects on distant tissues
[21]. However, effects of MSC have also been shown to be promoted by contact with target
cells such as leukocytes or EC (reviewed by [2]). The ability of MSC to dampen the inflamma-
tory response of leukocytes is greater when direct contact is made [22–25]. In addition, intra-
articular injection of MSC reduced inflammation to a greater extent than intravenous infusion
in murine collagen-induced arthritis [26]. One might suggest that site-specific injection of
MSC, allowing them to come into close contact with vascular endothelium, would be optimal
in therapy. However, experimental evidence is lacking as to how important contact is for
MSC-EC interactions that regulate leukocyte recruitment specifically.
Residing in the perivascular niche, MSC have the potential to communicate directly with
neighbouring endothelium to regulate leukocyte recruitment during inflammation [4, 27–31].
However, very few studies have examined this. In response to pro-inflammatory cytokines,
such as TNFα, EC up-regulate adhesion molecules, chemokines and lipid mediators necessary
to support the multi-step leukocyte recruitment cascade. Conditioned media from human
BMMSC have been reported to reduce the adhesion of a monocytic cell line (U937) to TNFα-
stimulated pulmonary endothelial cells in vitro, by tightening endothelial adheren junctions
(VE-cadherin and β-catenin) [32]. Indeed, we have previously demonstrated that co-culture of
BMMSC in direct contact with endothelial cells suppressed TNFα-induced recruitment of cir-
culating neutrophils and lymphocytes [4].
In this study we compared the potency of MSC isolated from different sources [bone mar-
row (BM), Wharton's jelly (WJ), and trabecular bone (TB)] in regulating the recruitment of
neutrophils to cytokine-treated EC, a key process in inflammation. We hypothesised that MSC
from different tissue sources may differ in their ability to suppress endothelial recruitment of
neutrophils. To mimic conditions where MSC had different proximities to EC, we utilised dis-
tinct models: MSC were incorporated within an endothelial monolayer; MSC and EC were cul-
tured on opposite sides of a Transwell filter or MSC were cultured below but separate from EC
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cultured on a Transwell filter above. We observed that the different MSC types were all capable
of suppressing neutrophil recruitment, although the required proximity varied. Conditioned
media from co-cultures were also bioactive, and IL-6 was identifiable as a common soluble
mediator of suppression. Our data suggest that the ability of endogenous MSC to limit the
inflammatory infiltrate through cross-talk with EC is a characteristic shared by diverse tissues.
Isolated MSC may have varying potency and requirement for contact with EC for their thera-
peutic effects depending on their origin. However, released soluble mediators might have
effects on inflammation in a target organ if cross-talk with EC is initiated by infused MSC in a
remote organ as well as by locally injected MSC.
Materials and Methods
Isolation, culture and characterisation of human MSC
Commercially available primary human bone marrow MSC (BMMSC; Lonza Ltd., Basel, Swit-
zerland) were obtained from healthy donors at passage 2 and expanded three times in culture
(i.e., to passage 5) in MSCGM Bulletkit (Lonza Ltd., Basel, Switzerland). Based on manufactur-
er’s information, cells had undergone ~11–12 doublings at passage 5, and underwent ~2.25
population doublings per passage.
Foetal Wharton’s jelly-derived MSC (WJMSC) were isolated from umbilical cords and
expanded to passage 3 as previously described [33]. Briefly, blood vessels were resected and tis-
sue pieces were suspended in phosphate buffered saline (PBS) containing 1mg/ml collagenase
type II and 1mg/ml hyaluronidase (all from Sigma-Aldrich, Poole, UK) at 37°C on a rotator for
5h. The cell suspension was filtered and centrifuged at 400g for 5min. WJMSC were resus-
pended in Low Glucose DMEM with stable L-Glutamine (Biosera, ZI du Bousquet, France)
supplemented with 10% foetal calf serum (FCS), 100U/ml penicillin and 100μg/ml streptomy-
cin (all from Sigma). At passage 3 WJMSC had undergone ~8–9 population doublings, and
consistently underwent ~2.5 population doublings per passage.
Trabecular bone explants were obtained from elderly osteoarthritis patients (above the age
of 60) undergoing joint replacement surgery (in collaboration with Dr Andrew Filer, University
of Birmingham, UK). Bone explants were transferred to culture flasks and grown in MSC
medium for 2 weeks to allow trabecular bone-derived MSC (TBMSC) to migrate away from
the tissue, at which point the fragments were removed. Adherent TBMSC were then cultured
to confluence and expanded to passage 3 (~10–11 population doublings). Although BMMSC
and TBMSC were isolated from the same tissue source, BMMSC were obtained from BM aspi-
rates while TBMSC were isolated from explant cultures of trabecular bone fragments.
WJMSC and TBMSC were used at passage 3 and BMMSC at passage 5 for experiments,
unless otherwise stated.
All cultured cell populations were characterised as MSC based on the International Society
for Cell Therapies criteria for defining MSC [34] (Fig 1). For surface marker expression, MSC
were incubated for 20min at 4°C with one of the following antibodies diluted in PBS with
0.15% bovine serum albumin (Sigma): CD44-APC, CD73-FITC, CD90-BV421, CD105-Per-
CP-Cy5.5, CD271-AF647, CD34-PE, CD45-PE, IgG1-FITC, IgG1-PerCP-Cy5.5, IgG2-APC,
IgG1-AF647 (all from BD Biosciences), CD146-AF647, IgG1-BV421 (Biolegends; London,
UK),CD14-PE, CD20-PE (Immunotools, Friesoythe, Germany), IgG1-PE (ebiosciences). MSC
were evaluated using a Cyan ADP flow cytometer and data were analysed offline using Summit
4.3 (both Beckman Coulter Inc., Pasadena, USA). Data are expressed as the percentage of cells
positively expressing the marker of interest using the isotype control to gate cells with negative
expression (Table 1; Fig 1A).
MSC As Endogenous Regulators of Neutrophil Recruitment
PLOS ONE | DOI:10.1371/journal.pone.0155161 May 12, 2016 3 / 18
To assess differentiation of MSC, cells were cultured for 14 or 21 days in Osteogenic Differ-
entiation, Adipogenic Induction (both from Lonza) or MesenCult-ACF Chondrogenic Differ-
entiation (STEMCELL Technologies, Cambridge, UK) according to the manufacturer’s
instructions. All samples were fixed in 10% neutral buffered formalin (Sigma) for 30min.
MSC-derived adipocytes were treated with 60% isopropanol (Sigma) and stained for 30min
with 0.3% Oil Red O (Sigma) dissolved in isopropanol. MSC-derived osteoblasts were stained
for 45min with Alizarin Red dye (Sigma) dissolved in distilled water. Samples were washed in
distilled water and counterstained with haemotoxylin solution (Sigma). MSC-derived chrondo-
cytes were dehydrated in ethanol, embedded in paraffin, sectioned and stained for 24h with
10μg/ml Alcian Blue 8GX (Alfa Aesar, Lancashire, UK) dissolved in a 3:2 ethanol to acetic acid
Fig 1. Characterisation of MSC isolated from different tissue sources. (A) Expression of MSCmarkers CD44, CD73, CD90, CD105, CD146, CD271
and combined expression of the haematopoietic markers CD14, CD20, CD34 and CD45 by BMMSC,WJMSC, or TBMSC by flow cytometry. Data are
expressed as representative histograms compared to isotype controls and are representative of n = 3 independent experiments using 3 different MSC
donors. (B) BMMSC,WJMSC, and TBMSC were differentiated towards osteoblast, adipocyte, or chrondocyte lineage for 14 or 21 days. Adipogenic,
osteogenic and chrondogenic differentiation were assessed using Oil Red O, Alizarin Red or Alcian Blue to stain lipid droplets, calcium deposits or cartilage
specific proteoglycans respectively. Phase contrast and colour micrographs are representative of n = 3 independent experiments using 3 different MSC
donors. Scale bar represents 10μm.
doi:10.1371/journal.pone.0155161.g001
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solution and nuclear fast red (Vector, Peterborough, UK). Cells were imaged using phase con-
trast microscopy and digitised images were acquired using a EVOS FL Imaging System
(Thermo Scientific, Loughborough, UK) (Fig 1B).
Isolation and culture of EC
Human umbilical vein endothelial cells (HUVEC) were isolated from umbilical cords as previ-
ously described [33, 35] and cultured in Medium 199 (Life Technologies, Paisley, UK) supple-
mented with 20% FCS, 35μg/ml Gentamycin, 10ng/ml epidermal growth factor, 1μg/ml
hydrocortisone (all from Sigma) and 2.5 μg/ml Amphotericin B (Life Technologies).
Isolation of neutrophils
Venous blood was collected from healthy donors into EDTA tubes (Sarstedt, Leicester, UK).
Neutrophils were isolated by two-step histopaque density centrifugation as previously
described [4, 33]. Purified neutrophils were washed twice in PBS containing 1mM Ca2+,
0.5mMMg2+ and 0.15% bovine serum albumin (PBSA; all from Sigma) at 250g for 5min. Neu-
trophils were counted and re-suspended to 2x106 cells/ml in PBSA.
Ethics
The study was conducted in compliance with the Declaration of Helsinki. All human samples
were obtained with written, informed consent and approval from the Human Biomaterial
Resource Centre (Birmingham, UK), West Midlands and Black Country Research Ethics Com-
mittee or University of Birmingham Local Ethical Review Committee.
EC and MSC co-culture in channel slides
Primary EC were dissociated using trypsin/EDTA (Sigma) and seeded in pre-coated channel
slides (μ-Slide VI; ibidi GmbH, Martinsried, Germany) at a density that would yield a confluent
monolayer within 24h [4, 33]. After 24h, MSC were dissociated, counted and labelled with
5μMCell Tracker Green (Life Technologies) for 30min (1.5x105 cells/ml in MSCGM), and
seeded onto the EC (~13,500 MSC per channel) and allowed to settle for 1h as described [4,
33]. Non-adherent cells were removed by washing with MSCGM, and the numbers of EC and
of fluorescent MSC were counted in 5 fields (Fig 2A). The ratio of MSC:EC was then calculated.
Cells were co-cultured in direct contact for 24h prior to treatment with or without 100U/ml
tumour necrosis factor–alpha (TNFα; R&D Systems, Abingdon, UK) for a further 4h. EC
mono-cultures were set up in parallel as controls.
Table 1. Percentage of MSC expressing surfacemarkers.
Surface Marker BMMSC WJMSC TBMSC
CD44 97.94 ± 0.67 98.34 ± 0.56 99.07 ± 0.88
CD73 96.91 ± 1.58 99.47 ± 0.26 94.68 ± 0.90
CD90 97.81 ± 0.69 98.06 ± 1.07 97.52 ± 2.00
CD105 97.61 ± 0.47 96.39 ± 1.46 90.50 ± 4.68
CD146 46.08 ± 6.12 90.71 ± 5.10 24.64 ± 9.46
CD271 32.79 ± 0.50 53.91 ± 3.23 19.31 ± 8.61
Haematopoietic markers 9.31 ± 6.17 3.98 ± 1.86 6.47 ± 0.45
Haematopoietic markers, CD14, CD20, CD34 and CD45, were stained in combination in a single tube. Data are percentage mean ± SEM, for n = 5
independent experiments, with the exception of staining for CD146 and CD271 on all MSC types and all analysis of TBMSC where n = 3.
doi:10.1371/journal.pone.0155161.t001
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EC and MSC co-culture on Transwell filters
MSC-EC co-cultures were established on opposite sides of 0.4μm pore Transwell filter inserts
(BD Pharmingen, Cowley, UK) as previously described [4, 33]. Briefly, MSC (5x105) were
seeded onto inverted filters and cultured for 24h. EC were then seeded on the inner surface of
the inserts in close proximity. Alternatively, co-cultures were established by seeding MSC onto
the bottom of a 6-well plate for 24h and seeding EC above inside the filter so the two cell types
were separated [36]. Cells were co-cultured for 24h prior to treatment with TNFα as above.
Parallel endothelial mono-cultures were set up as controls.
To investigate the bioactivity of co-culture conditioned media, supernatants were collected from
EC andMSCmono- and co-cultures at 24h. Fresh ECmono-cultures were treated with conditioned
media for 24h prior to stimulation with TNFα in the same conditioned media for a further 4h.
Fig 2. Effect of MSC from different tissues on neutrophil recruitment when cultured in direct contact with EC.
BMMSC,WJMSC, or TBMSC were cultured in direct contact with EC in channel slides for 24h before addition of 100U/ml
TNFα for 4h. (A) MSC labelled with Cell Tracker Green integrated into the ECmonolayer. Fluorescent micrographs are
representative of n = 3 independent experiments using 3 different MSC donors. (B) Ratio of MSC to EC for each co-
culture assessed after the adhesion assay. ANOVA showed a significant effect of MSC source on MSC:EC ratio, p<0.05;
n = 3 independent experiments, using 3 different MSC donors for each MSC type. (C) Neutrophil adhesion expressed as
a proportion of that observed on the paired ECmono-culture control. ANOVA showed a significant effect of culture
conditions on adhesion, p<0.01; n = 5 independent experiments, using 3 different BMMSC, 5 WJMSC and 5 TBMSC
donors. Data are mean ± SEM, incorporating a different EC and neutrophil donor in each experiment. * = p<0.05 and
** = p<0.01 compared to ECmono-cultures a by Dunnett post-test.
doi:10.1371/journal.pone.0155161.g002
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In some experiments, a neutralising antibody against either IL-6 (5μg/ml; clone 6708) or a
function blocking antibody against membrane IL-6 receptor (IL-6R; 5μg/ml; clone 17506; all
from R&D Systems) was added when co-cultures were established in close proximity on opposite
sides of porous insert and were present throughout the co-culture and cytokine-stimulation.
Flow-based adhesion assay
Flow based adhesion assays were performed for channel slides or filters incorporated into a
custom-made parallel-plate flow chamber using phase-contrast digital microscopy as previ-
ously described [4, 33]. Purified leukocytes were perfused over EC for 4min followed by wash-
out with cell-free PBSA at 0.05PA (microslide model) or 0.1Pa (filter model). Digitised
recordings of 5–10 random fields were made at 2 and 9 minutes after the end of the neutrophil
bolus to assess neutrophil adhesion and transmigration respectively. Images were analysed off-
line using Image-Pro Plus software (Media Cybernetics, Marlow, UK). Total leukocytes bound
to the endothelium were counted, and classified as either: (i) phase bright, rolling, or stationary
adherent on the apical surface or (ii) phase-dark, spread and transmigrated under the endothe-
lial monolayer. The numbers of adherent and of transmigrated neutrophils were averaged per
field. Values for co-cultures were expressed as a proportion of those observed on the paired EC
mono-culture control.
Quantification of IL-6
Culture supernatants were obtained from unstimulated EC and MSC cultured alone or in co-
culture for 24h. IL-6 was quantified using IL-6 DuoSet ELISA (R&D Systems) according to
manufacturer's instructions.
Gene expression analysis
Endothelial mRNA was isolated from EC mono-cultures and EC-BMMSC co-cultures using
the RNeasy Mini Kit (Qiagen, Crawley, UK), converted to cDNA and analysed by qPCR using
Universal PCR mastermix (Life Technologies) according to manufacturer’s instructions. Prim-
ers were bought as Assay on Demand kits from Applied Biosystems. Genes of interest were
amplified using the 7900HT Real-Time PCR machine, analysed using SDS 2.2 (Applied Biosys-
tems) and expressed as 2-ΔCT (relative to 18S).
Statistical analysis
Data are expressed as mean ± SEM, where a different EC and leukocyte donor were used for
each experiment. Between 3–5 different MSC donors were incorporated in each experiment for
each biological replicate for TB and WJ (i.e. 3–5 biological replicates per experiment), and 2–3
donors for BM. Multi-variant data when paired were analysed using analysis of variance
(ANOVA), followed by Bonferroni or Dunnett post-hoc test. Paired t-test was used when mul-
tiple parameters were grouped together even though not all conditions were tested in every
experiment, but EC mono-culture controls were performed on each occasion. p<0.05 was con-
sidered statistically significant.
Results
Characterisation of primary MSC isolated from different tissue sources
BMMSC, WJMSC and TBMSC were initially characterised based on the expression of known
MSC markers and the capacity to undergo differentiation into adipocytes and osteoblasts [34].
BMMSC, WJMSC, and TBMSC all expressed the markers CD44, CD73, CD90, and CD105
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upon their surface, with little if any contaminating haematopoietic progenitors based on the
expression of CD14, CD20, CD34, and CD45 (Fig 1A). Interestingly, only BMMSC and
WJMSC expressed CD146, while all 3 MSC populations expressed CD271 (Fig 1A). All MSC
types exhibited the capacity to differentiate down the adipogenic, osteogenic and chondrogenic
lineages, although WJMSC-derived adipocytes were observed to have fewer lipid droplets
when compared to BMMSC- or TBMSC-derived adipocytes (Fig 1B).
Effects of MSC from different tissue sources on neutrophil recruitment by
inflamed EC
We previously reported that BMMSC were able to suppress leukocyte recruitment to tumour
necrosis factor–alpha (TNFα)-stimulated EC when integrated into the EC monolayer, using
channel slides to mimic systemic infusion of MSC [4]. Using this model, we compared the abil-
ity of human MSC isolated from different tissues (BM, WJ and TB) to regulate neutrophil
recruitment. Although MSC were seeded at the same density, more TBMSC adhered to the EC
monolayer than BMMSC and WJMSC (Fig 2A and 2B). Co-culture with MSC from different
tissues suppressed neutrophil recruitment to TNFα-stimulated EC to a similar extent when
incorporated into the EC monolayer (Fig 2C).
To mimic the effect of tissue-resident MSC, or those administered directly into tissue, we
cultured MSC and EC in close proximity, but not in direct contact, prior to assessing neutro-
phil recruitment from flow [4, 30, 33]. Once again, we observed that all 3 MSC types were capa-
ble of suppressing neutrophil adhesion to TNFα-stimulated EC to a similar extent (Fig 3A).
Co-culture did not have a significant effect on neutrophil migration through the endothelial
monolayer when compared to EC cultured alone (Fig 3B). Using WJMSC as an example, we
observed that the reduction in neutrophil adhesion increased with increasing number of MSC
added to the co-culture, with the greatest effects obtained with 5x105 WJMSC (Fig 3C). The
number of neutrophils undergoing transmigration was not significantly altered by the number
of MSC (Fig 3D). Further experiments were performed using the filter-based model incorpo-
rating 5x105 MSC, unless otherwise stated.
Effects of passage on immunomodulation by MSC
We tested whether passagingMSC altered their ability to regulate neutrophil recruitment. Ex vivo
expansion of BMMSC to p7 (Fig 4A) and p9 (data not shown) completely abrogated their ability
to suppress neutrophil adhesion, as compared to p5 BMMSC. In contrast, WJMSCmaintained the
capacity to limit neutrophil recruitment up to p7, compared to p5WJMSC (Fig 4B) and p3 (data
not shown), although the potency of this effect gradually reduced over passage. Effects of passage
were not assessed for TBMSC as they grew considerably slower than the other MSC types, presum-
ably due to the fact that the cells were isolated from elderly patients with osteoarthritis.
Effects of proximity between MSC and EC and of co-culture
supernatants on neutrophil recruitment
To assess whether close proximity was essential for crosstalk between MSC and EC, MSC were
cultured on the plate below, separated by 0.9mm from the EC cultured above on the filter.
When MSC and EC were separated, BMMSC were still capable of significantly reducing neu-
trophil adhesion, albeit to a slightly lesser extent than when the two cell types were cultured on
opposite sides of a filter (Fig 5A). In contrast, separating WJMSC or TBMSC from EC during
co-culture nullified their inhibitory effects on neutrophil adhesion (Fig 5B and 5C). Thus MSC
MSC As Endogenous Regulators of Neutrophil Recruitment
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varied depending on their source in their requirement for proximity to EC for functional
efficacy.
Next we examined whether MSC-EC co-culture on opposite sides of filters led to the release
of bioactive soluble agents, as previously described for MSC integrated into EC monolayers [4].
EC mono-cultures were incubated for 24h with conditioned media from MSC mono-cultures
or co-cultures prior to cytokine-stimulation. Co-culture conditioned media from each MSC
type mimicked the effect of MSC-EC co-culture, inhibiting neutrophil adhesion to TNFα-
treated EC mono-cultures (Fig 6). In contrast, media fromMSC mono-culture had no effect on
adhesion (Fig 6). Thus all MSC types caused the release of bioactive immuno-protective agents
when cultured with EC, which regulated the inflammatory infiltrate.
Role of IL-6 in regulating recruitment in MSC co-cultures
We previously showed that IL-6 contributed to the reduction in leukocyte adhesion when EC
were cultured in direct contact with BMMSC or in close proximity to fibroblasts [4, 30]. Here
Fig 3. Effect of MSC from different tissues on neutrophil recruitment when cultured on the opposite side of the
filter to EC.MSC and EC were cultured on opposite sides of 0.4μm porous filters for 24h prior to stimulation with 100U/
ml TNFα for 4h. Co-cultures formed with (A-B) MSC from different sources (BM, WJ, TB) or (C-D) with different numbers
of WJMSC. Neutrophil (A,C) adhesion and (B,D) migration were expressed as a proportion of values observed on the
paired ECmono-culture control. In A and C, ANOVA showed a significant effect of culture conditions on neutrophil
adhesion, p<0.001. Data are mean ± SEM from (A-B) n = 11–13 and (C-D) n = 3–5 experiments incorporating a different
EC and neutrophil donor in each. (A-B) 3 different BMMSC, 5 different WJMSC and 5 different TBMSC donors were
used and (C-D) 5 different WJMSC donors were used, with the exception of 3x105 cells where 3 different donors were
used * = p<0.05 and ** = p<0.01 compared to ECmono-cultures by Dunnett post-test.
doi:10.1371/journal.pone.0155161.g003
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inhibition of IL-6 signalling using antibodies that targeted soluble IL-6 or membrane IL-6R
both significantly reduced the inhibitory effects of BMMSC andWJMSC in co-culture (Fig 7).
IL-6 secretion by co-cultures
Additionally, we have reported that BMMSC co-culture with EC induced a marked increase in
IL-6 secretion when the two cell types were in direct contact [4]. Here, we detected a signifi-
cantly more IL-6 released from co-cultures incorporating all MSC types, either incorporated
within the EC monolayer (Fig 8A) or in close proximity on opposite sides of a filter (Fig 8B),
compared to the sum of the EC and MSC mono-cultures. Separating MSC from EC reduced
the amount of IL-6 secreted in comparison to when the two cell types were cultured on oppo-
site sides of a filter (Fig 8C). However, the level of IL-6 produced when MSC-EC were separated
was still higher than that released from individual mono-cultures (Fig 8C). Similar observa-
tions were made for MSC from all sources, suggesting IL-6 was a common soluble effector.
We also measured IL-6 generated by co-cultures incorporating BMMSC or WJMSC at a
higher passage to evaluate whether IL-6 levels correlated with changes in the suppression of
neutrophil recruitment upon MSC passage shown in Fig 4. Perhaps surprisingly, IL-6 secretion
by co-cultures was not affected by passage and remained much higher than mono-cultures for
both BMMSC and WJMSC (Fig 8D and 8E). Thus although IL-6 was a common effector of
immunomodulation, levels were not closely associated with the degree of immunosuppression
during passage and indicated a role for additional soluble co-factor(s) that presumably did vary
with passage.
Analysis of gene expression in endothelial cells upon co-culture with
BMMSC
To further investigate the mechanism underlying the suppression of neutrophil adhesion, we
analysed the expression of adhesion molecules by EC using qPCR. BMMSC tended to reduce
the gene expression of the capture receptor E-selectin (0.07 ± 0.08 2-ΔCT) and the β2-integrin
Fig 4. Effects of passage on the ability of MSC to suppress neutrophil recruitment. (A) BMMSC or (B) WJMSC at
different passage number were co-cultured with EC on opposite sides of a porous filter for 24h prior to stimulation with
TNFα for 4h. Neutrophil adhesion was expressed as a proportion of that observed on the paired ECmono-culture
control. In A and B, ANOVA showed a significant effect of passage on neutrophil adhesion, p<0.01. Data are
mean ± SEM from (A) n = 13 for EC, n = 13 p5 MSC-EC and n = 3 p7 MSC-EC co-cultures and (B) n = 3 for all data
independent experiments using a different EC and neutrophil donor in each experiment. (A) 5 or 3 different BMMSC
donors were used at p5 or p7 respectively; and (B) 3 different WJMSC donors were used at both passages. ** = p<0.01
compared to ECmono-cultures by Dunnett post-test.
doi:10.1371/journal.pone.0155161.g004
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Fig 5. Effects of varying proximity between MSC and EC on neutrophil recruitment. Co-cultures were
formed by seeding BMMSC,WJMSC, or TBMSC on the opposite side of a Transwell filter to EC (Close
proximity) or by seeding MSC on the plate below EC cultured on a filter (Separate). Neutrophil adhesion was
expressed as a proportion of that observed on the paired ECmono-culture control where a different EC and
neutrophil donor was used in each experiment. ANOVA showed a significant effect of culture conditions on
neutrophil adhesion for each type of MSC, p<0.01. Data are mean ± SEM, n = 11 for EC alone and close
proximity co-cultures or n = 3 for separate co-cultures. (A) 5 or 2 different BMMSC donors were used for close
proximity or separate cultures respectively, (B) 3 different WJMSC and (C) 3 different TBMSC donors were
used for both culture models. * = p<0.05 and ** = p<0.01 compared to ECmono-cultures by Dunnett post-
test.
doi:10.1371/journal.pone.0155161.g005
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ligand ICAM-1 (0.84 ± 0.18 x10-6 2-ΔCT) by EC in co-cultures compared to EC mono-cultures
(19.04 ± 7.6 2-ΔCT and 27 ± 9.26 x10-6 2-ΔCT respectively; mean ± SEM, n = 3).
Fig 6. Effects of media conditioned by MSC alone or in co-culture with EC on neutrophil recruitment.
ECmono-cultures were treated with conditioned media from BMMSC,WJMSC, or TBMSC either cultured
alone or co-cultured with EC on opposite sides of filters for 24h. Not all conditions were performed in all
experiments, but treated cells were always compared to paired untreated EC controls. Neutrophil adhesion
was assessed at 2min post-perfusion and expressed as a proportion of that observed on the paired EC
mono-culture control. ANOVA showed a significant effect of culture conditions on neutrophil adhesion for
each type of MSC, p<0.01. Data are mean ± SEM from n = 3 independent experiments using a different EC
and neutrophil donor in each experiment. (A) 2 different BMMSC, (B) 3 different WJMSC and (C) 3 different
TBMSC donors were used. * = p<0.05 compared to EC cultured without conditioned media by Dunnett post-
test.
doi:10.1371/journal.pone.0155161.g006
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Discussion
MSC are tissue-resident stromal cells with immunomodulatory and reparative properties,
which we recently showed to be able to suppress leukocyte recruitment [4]. Here we compared
the ability of MSC isolated from bone marrow aspirates, umbilical cordWharton's jelly and tra-
becular bone explants to regulate adhesion of flowing neutrophils to cytokine-treated EC. Co-
culture models were used with different degrees of proximity between the MSC and EC. MSC
from these tissues showed similar capability in suppressing neutrophil recruitment. However,
WJMSC appeared to retain their effects at higher passage than BMMSC, and we were not able
to maintain TBMSC in culture to high passage. On the other hand, BMMSC retained a stronger
effect when physically separated from EC by a small gap (~900μm) than the other MSC types.
Conditioned media from all co-cultures suppressed neutrophil recruitment, and IL-6 was iden-
tified as a common bioactive mediator. Immuno-protective effects diminished with passage,
although IL-6 levels remained high indicating that IL-6 did not act alone. Thus, MSC may be
tissue-resident cells that communicate with EC, acting as endogenous regulators of inflamma-
tory infiltrates. From a therapeutic standpoint, potency, requirement for close contact with EC
and variation with passage varied slightly for MSC from the different tissues.
In general, MSC mediate their effects through the release of soluble factors, although these
effects can be enhanced by direct MSC-target cell interaction (reviewed by [2]). The immuno-
protective effects we report here were transferable in the conditioned media from all MSC
types in co-culture. Importantly, we observed that a two-way conversation between MSC and
EC was essential to generate the bioactive agent(s), as conditioned media fromMSC mono-cul-
tures were unable to suppress neutrophil recruitment. The need for cross-talk for effects on
recruitment of leukocytes is consistent with previous reports [4, 32, 33, 37]. Specifically, we
found that cross-talk was necessary to generate the high levels of IL-6 found in co-culture
supernatants, which originated mainly from the MSC [4]. Here, IL-6 was an active agent in all
the conditioned media. IL-6 can have either pro- or anti-inflammatory effects in different
Fig 7. Effect of blocking the actions of IL-6 on the immunosuppressive effects of MSC in co-culture. (A) BMMSC or (B) WJMSC
co-cultures were cultured in close proximity, on opposite sides of a porous filters for 24h and then treated with neutralising antibodies
against IL-6 or a function blocking antibody against IL-6R for the duration of the co-culture and cytokine treatment. Neutrophil adhesion
was expressed as a proportion of that observed on the paired ECmono-culture. ANOVA showed a significant effect of co-culture
treatment on neutrophil adhesion in (A) (p<0.05) and (B) (p<0.01). Data are mean ± SEM, n = 3–4 independent experiments using a
different EC and neutrophil donor in each experiment. (A) 3 different BMMSC and (B) 4 different WJMSC donors were used. * = p<0.05
and ** = p<0.01 compared to untreated MSC co-cultures by Dunnett post-test.
doi:10.1371/journal.pone.0155161.g007
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conditions, including increasing or decreasing leukocyte recruitment [4, 29, 30], or switching
recruitment from neutrophils to mononuclear leukocytes (e.g. [4, 29, 30, 38]), presumably
depending on other co-factors present. We recently showed complementary roles for IL-6, sol-
uble IL-6 receptor and TGFβ in immunosuppression when MSC and EC were cultured in
direct contact [4]. Here although IL-6 was a common effector of immunomodulation, levels
remained high during passage as the degree of immunosuppression decreased; indicating role
(s) for additional soluble co-factor(s) that presumably did vary with passage. Moreover, the
partial reduction in gene expression for key adhesion molecules (E-selectin and ICAM-1), may
also help to explain, in part at least, changes in recruitment observed.
Given the clear role for released soluble mediators, we wondered whether cell-cell contact
was required for MSC-EC cross-talk. Culturing MSC and EC on opposite sides of thin micro-
porous filters separated the 2 cell types by ~10μm, although the 0.4μm pores may have allowed
interactions via the tips of protruding pseudopods. This format was as effective as mixed cul-
ture on a surface [4]. Increasing the distance between MSC and EC tended to reduce efficacy of
immuno-suppression. Efficacy was retained best by BMMSC, which may indicate a variation
in the sensitivity of the MSC from different tissues to substance(s) released by EC. The distance
from the filter to the bottom of the well in the separated co-cultures was ~900μm, which is
larger than the expected distance in vivo between tissue-resident cells and local blood
Fig 8. Effects of co-culture, of proximity between MSC and EC andMSC passage on IL-6 secretion.MSC-EC co-cultures were formed (A)
in direct contact using channel slides; (B, D-E) in close proximity on opposite sides of a porous filter; or (C) in close proximity or with MSC
seeded below and separate from EC on the filter above. EC and MSCmono-cultures (at p3 for WJMSC and p5 for BMMSC) were set up as
controls. IL-6 release into supernatants was assessed after 24h. In (D) and (E), ANOVA showed a significant effect of culture conditions,
p<0.01. Data are mean ± SEM from (A) n = 4–8 (B) n = 3–19 where ECmono-cultures (n = 19); BMMSCmono-cultures (n = 13); EC:BMMSC
(n = 16); WJMSCmono-cultures (n = 3); EC:WJMSC (n = 10); TBMSCmono-cultures (n = 4); EC:TBMSC (n = 7), (C-E) n = 3 independent
experiments using a different EC and neutrophil donor in each experiment. (A-E) 5 different BMMSC, 3 different WJMSC and 3 different TBMSC
donors were used. ** = p<0.01 compared to the sum of the EC and respective MSCmono-cultures supernatant unless otherwise indicated by
paired t-test in A-C, or by Dunnett post-test in D-E.
doi:10.1371/journal.pone.0155161.g008
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microvessels ~200um. Thus in vivoMSC may be able to communicate with EC with or without
direct contact to modulate inflammatory infiltrates. These considerations are relevant to thera-
peutic utility of MSC. Delivery via intravascular infusion would bring MSC directly to the
endothelial surface. While the MSC might be delivered to a number of sites as well as the target
organ, soluble mediators generated by cross-talk at those sites could also have efficacy via
release into the systemic circulation (e.g. [21]). Our results predict that direct injection of MSC
into tissue would also be efficacious, if the cells achieved adequately close contact with the vas-
cular endothelium. It is also worth considering that knowledge of the bioactive agents gener-
ated in co-cultures along with IL-6 might allow their delivery for 'cell-free' therapy, which
mimics the protective effects of MSC.
Previous studies showed, as here, that the immunomodulatory effects of MSC varied with
the time in culture or passaging [9–12] and ratio of MSC-to target cell [39–41]. The effects of
passage could have significant impact on clinical benefit. Here we demonstrated that WJMSC
better maintained their potency in culture with passage, compared to BMMSC whose effects
on EC were lost by passage seven. Others found that MSC derived from umbilical cord (effec-
tively WJMSC) retained their effects on T-cell proliferation to much higher passage [9, 12].
Comparison of the potency of different types of MSC is difficult because it may depend on
readout chosen. For instance, MSC derived from umbilical cord had similar effects on mono-
nuclear cell proliferation compared to BMMSC [21]. We found that while BMMSC and
WJMSC induced similar suppression of neutrophil recruitment, BMMSC lost this capacity
more quickly with in vitro expansion, but could operate at greater distances from EC in com-
parison to WJMSC. TBMSC were also able to suppress recruitment but proved difficult to
expand beyond passage three.
In conclusion, endogenous MSC from several tissues were able to communicate with EC to
limit inflammatory infiltrates, producing a common bioactive agent in IL-6. There was no
clearly-superior type of MSC for therapeutic use, although the stability in culture of WJMSC
may be advantageous. Our results support the concept that MSC are endogenous tissue-resi-
dent regulators of inflammation. Variations in the MSC niche between organs and the capacity
of MSC to respond to changes in the local microenvironment [7–8, 42–44] suggest that modu-
lation of their generic immunomodulatory capability might contribute to tissue-specific varia-
tions in susceptibility to inflammation or patterns of leukocyte recruitment. Mesenchymal
stromal cells from a variety of healthy tissues also exhibit immunosuppressive capabilities [4,
28, 30], while cells from diseased tissue may induce inflammatory infiltrates [29–30]. The fore-
going suggests the intriguing possibility that changes in the local MSC microenvironment
could adversely influence MSC function.
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